Current price is more than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

ROE vs FD rates

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Delta Corp Ltd, Dish TV India Ltd, Spandana Sphoorty Financial Ltd and Jyothy Labs Ltd are among the other gainers in the BSE’s ‘A’ group today, 17 June 2022.

Centrum Capital Ltd leads gainers in ‘A’ group

Stocks to Watch: Check out the companies making headlines before the opening bell.

Stocks to Watch Today | RIL, Usha Martin, Jyothy Labs and others in news today

YES Securities is bullish on Jyothy Labs has recommended buy rating on the stock with a target price of Rs 181 in its research report date May 24, 2022.

Buy Jyothy Labs; target of Rs 181: YES Securities

ICICI Direct recommended hold rating on Jyothy Laboratories with a target price of Rs 145 in its research report dated May 25, 2022.

Hold Jyothy Laboratories; target of Rs 145: ICICI Direct

Sharekhan is bullish on Jyothy Labs has recommended buy rating on the stock with a target price of Rs 175 in its research report dated May 24, 2022.

Buy Jyothy Labs: target of Rs 175: Sharekhan

Motilal Oswal recommended Neutral rating on Jyothy Laboratories with a target price of Rs 150 in its research report dated May 24, 2022.

Neutral Jyothy Laboratories; target of Rs 150: Motilal Oswal

Jyothy Labs Standalone March 2022 Net Sales at Rs 537.37 crore, up 10.28% Y-o-Y

Jyothy Labs Q4 Review - All Efforts On Maintaining Growth Momentum Despite Margin Pressures: Yes Securities

Its revenue from operations rose 10.42 per cent to Rs 546.71 crore during the period under review from Rs 495.11 crore in the year-ago period

Jyothy Labs Q4 net profit rises 35% to Rs 36.9 cr; revenue rises 10%

Nalanda India Equity Fund Ltd on Monday bought FMCG company Jyothy Laboratories’ shares worth Rs 96 crore through an open market transaction.

Nalanda India Equity Fund buys Jyothy Labs shares worth Rs 96 crore

Net Sales are expected to increase by 7.8 percent Y-o-Y (down 0.6 percent Q-o-Q) to Rs 525.5 crore, according to Motilal Oswal.

Jyothy Labs Q4 PAT may dip 25.8% YoY to Rs 37.4 cr: Motilal Oswal

Jyothy Laboratories Limited is a multi-brand, multi-product FMCG company. It is principally engaged in manufacturing and marketing of fabric whiteners, soaps, detergents, mosquito repellents, scrubber, bodycare and incense sticks.

Jyothy Labs Ltd

Jyothy Labs Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Centrum Capital Ltd leads gainers in ‘A’ group

Stocks to Watch Today | RIL, Usha Martin, Jyothy Labs and others in news today

Buy Jyothy Labs; target of Rs 181: YES Securities

Hold Jyothy Laboratories; target of Rs 145: ICICI Direct

Buy Jyothy Labs: target of Rs 175: Sharekhan

Neutral Jyothy Laboratories; target of Rs 150: Motilal Oswal

Jyothy Labs Standalone March 2022 Net Sales at Rs 537.37 crore, up 10.28% Y-o-Y

Jyothy Labs Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Centrum Capital Ltd leads gainers in ‘A’ group

Stocks to Watch Today | RIL, Usha Martin, Jyothy Labs and others in news today

Buy Jyothy Labs; target of Rs 181: YES Securities

Hold Jyothy Laboratories; target of Rs 145: ICICI Direct

Buy Jyothy Labs: target of Rs 175: Sharekhan

Neutral Jyothy Laboratories; target of Rs 150: Motilal Oswal

Jyothy Labs Standalone March 2022 Net Sales at Rs 537.37 crore, up 10.28% Y-o-Y

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock